Enovis Corporation ENOV
Set alert
At close · Oct 30
After hours · Oct 30, 5:57 PM ET
- YTD
- -25.26%
- 1 year
- -35.13%
- Open
- 22.17
- Prev close
- 22.81
- Mkt cap
- 1.15B
- Vol
- 2.52M
- Avg vol
- 1.54M
- EPS
- -19.23
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 19.83
- High
- 22.26
- Forward P/E
- 5.64
- Beta
- 1.48
- Short ratio
- 7.14
- Inst. own
- 119.13%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 20.13
- 200-d avg
- 23.09
- 1y target
- 36.08
2Y chart
Events in this range
- Aug 7, 2025Earnings: 0.79; estimate 0.74; surprise 6.76%
- Nov 6, 2025Earnings: 0.75; estimate 0.67; surprise 11.94%
- Feb 26, 2026Earnings: 0.95; estimate 0.81; surprise 17.28%
- May 7, 2026Earnings: 0.89; estimate 0.82; surprise 8.54%
- Aug 6, 2026Earnings: 0.9; estimate 0.847; surprise 6.26%
- Aug 17, 2026Rating: Canaccord Genuity · Buy → Buy
- Sep 1, 2026Rating: BTIG · Buy → Buy
- Sep 2, 2026Rating: Freedom Capital Markets · Buy → Buy
- Sep 2, 2026Rating: Citizens · Market Outperform → Market Outperform
- Sep 2, 2026Rating: Wells Fargo · Overweight → Overweight
- Oct 12, 2026Rating: Needham · Buy → Buy
Signals (97)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 2 days ago |
| RSI: Overbought | Oct 29, 2026 | 3 days ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| MACD: Buy Signal | Sep 23, 2026 | 1 month ago |
| RSI: Oversold | Sep 10, 2026 | 1 month ago |
| RSI: Oversold | Sep 2, 2026 | 2 months ago |
| SMA: Bearish | Aug 27, 2026 | 2 months ago |
| SMA: Bearish | Aug 26, 2026 | 2 months ago |
| SMA: Bullish | Aug 25, 2026 | 2 months ago |
| SMA: Bearish | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 18, 2026 | 2 months ago |
| SMA: Bullish | Aug 18, 2026 | 2 months ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 13, 2026 | 2 months ago |
| SMA: Bullish | Aug 13, 2026 | 2 months ago |
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 6, 2026 | 2 months ago |
| SMA: Bullish | Jul 16, 2026 | 3 months ago |
| SMA: Bearish | Jul 14, 2026 | 3 months ago |
| SMA: Bullish | Jul 10, 2026 | 3 months ago |
| SMA: Bearish | Jul 7, 2026 | 3 months ago |
| SMA: Bullish | Jul 6, 2026 | 3 months ago |
| SMA: Bullish | Jul 6, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 2, 2026 | 4 months ago |
| MACD: Sell Signal | Jul 1, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 25, 2026 | 4 months ago |
| SMA: Bearish | May 27, 2026 | 5 months ago |
| MACD: Sell Signal | May 21, 2026 | 5 months ago |
| SMA: Bearish | May 8, 2026 | 5 months ago |
| SMA: Bullish | May 7, 2026 | 5 months ago |
| MACD: Buy Signal | May 7, 2026 | 5 months ago |
| SMA: Bullish | May 5, 2026 | 6 months ago |
| SMA: Bearish | Apr 28, 2026 | 6 months ago |
| SMA: Bullish | Apr 24, 2026 | 6 months ago |
| SMA: Bearish | Apr 23, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 23, 2026 | 6 months ago |
| SMA: Bullish | Apr 8, 2026 | 6 months ago |
| SMA: Bearish | Apr 2, 2026 | 7 months ago |
| MACD: Buy Signal | Apr 2, 2026 | 7 months ago |
| SMA: Bullish | Apr 1, 2026 | 7 months ago |
| SMA: Bearish | Mar 27, 2026 | 7 months ago |
| SMA: Bullish | Mar 26, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 13, 2026 | 7 months ago |
| SMA: Bearish | Mar 12, 2026 | 7 months ago |
| SMA: Bullish | Mar 11, 2026 | 7 months ago |
| SMA: Bearish | Mar 10, 2026 | 7 months ago |
| SMA: Bullish | Feb 26, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 6, 2026 | 8 months ago |
| RSI: Oversold | Jan 27, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 14, 2026 | 9 months ago |
| SMA: Bearish | Jan 12, 2026 | 9 months ago |
| SMA: Bullish | Jan 8, 2026 | 9 months ago |
| MACD: Buy Signal | Dec 22, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 4, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 26, 2025 | 11 months ago |
| SMA: Bearish | Nov 12, 2025 | 11 months ago |
| SMA: Bullish | Nov 11, 2025 | 11 months ago |
| SMA: Bearish | Nov 6, 2025 | 12 months ago |
| SMA: Bullish | Nov 4, 2025 | 12 months ago |
| SMA: Bearish | Oct 30, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 30, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 17, 2025 | 1 year ago |
| SMA: Bullish | Oct 14, 2025 | 1 year ago |
| SMA: Bearish | Oct 10, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 23, 2025 | 1 year ago |
| SMA: Bullish | Aug 22, 2025 | 1 year ago |
| SMA: Bearish | Aug 20, 2025 | 1 year ago |
| SMA: Bullish | Aug 19, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 7, 2025 | 1 year ago |
| RSI: Oversold | Jul 18, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 15, 2025 | 1 year ago |
| SMA: Bearish | Jul 14, 2025 | 1 year ago |
| SMA: Bullish | Jul 8, 2025 | 1 year ago |
| SMA: Bearish | Jul 7, 2025 | 1 year ago |
| SMA: Bullish | Jul 2, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 25, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 18, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 9, 2025 | 1 year ago |
| MACD: Sell Signal | May 21, 2025 | 1 year ago |
| SMA: Bearish | May 20, 2025 | 1 year ago |
| SMA: Bullish | May 12, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 22, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 3, 2025 | 1 year ago |
| RSI: Oversold | Apr 3, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 17, 2025 | 1 year ago |
| RSI: Oversold | Mar 10, 2025 | 1 year ago |
| RSI: Oversold | Feb 26, 2025 | 1 year ago |
| SMA: Bearish | Feb 6, 2025 | 1 year ago |
| SMA: Bullish | Feb 4, 2025 | 1 year ago |
| SMA: Bearish | Feb 3, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 3, 2025 | 1 year ago |
| SMA: Bullish | Jan 17, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 8, 2025 | 1 year ago |
| RSI: Overbought | Nov 27, 2024 | 1 year ago |
| RSI: Overbought | Nov 25, 2024 | 1 year ago |
Key statistics
- Market cap
- 1.15B
- Enterprise value
- 2.67B
- Trailing P/E
- 0.00
- Forward P/E
- 5.64
- PEG ratio
- 3.45
- Price / sales
- 0.50
- Price / book
- 0.78
- EPS (TTM)
- -19.23
- Beta
- 1.48
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -47.97%
- Revenue (TTM)
- 2.30B
- Revenue growth
- 3.20%
- Free cash flow
- 185.94M
- Total cash
- 12.56M
- Total debt
- 1.37B
- Return on equity
- -54.14%
- Shares outstanding
- 57.67M
- Short % of float
- 24.18%
- 50-day average
- 20.13
- 200-day average
- 23.09
Analyst view
Consensus: strong buy
- Target (low)
- 24.00
- Target (mean)
- 36.08
- Target (high)
- 47.00
- Strong buy2
- Buy10
- Hold1
- Sell0
- Strong sell0
Next earnings
Nov 5, 2026
Expected Nov 5, 2026. Consensus EPS estimate 0.76681.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2026 | Oct 3, 2026 | 0.767 | — | — | — |
| Aug 6, 2026 | Jul 3, 2026 | 0.847 | 0.90 | +0.05 | +6.26% |
| May 7, 2026 | Apr 3, 2026 | 0.82 | 0.89 | +0.07 | +8.54% |
| Feb 26, 2026 | Dec 31, 2025 | 0.81 | 0.95 | +0.14 | +17.28% |
| Nov 6, 2025 | Oct 3, 2025 | 0.67 | 0.75 | +0.08 | +11.94% |
| Aug 7, 2025 | Jul 4, 2025 | 0.74 | 0.79 | +0.05 | +6.76% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 12, 2026 | Needham | main | Buy | Buy |
| Sep 2, 2026 | Wells Fargo | main | Overweight | Overweight |
| Sep 2, 2026 | Citizens | main | Market Outperform | Market Outperform |
| Sep 2, 2026 | Freedom Capital Markets | main | Buy | Buy |
| Sep 1, 2026 | BTIG | main | Buy | Buy |
| Aug 17, 2026 | Canaccord Genuity | main | Buy | Buy |
About Enovis Corporation
Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions. The Reconstructive segment develops, manufactures, markets, and distributes surgical solutions that restore mobility and improve patient outcomes, which includes a range of differentiated implants, instrumentation, and enabling technologies used in elective and non-elective joint replacement, limb reconstruction, and foot and ankle procedures; and products for the hip, knee, shoulder, elbow, extremity reconstruction and fixation, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes a range of products which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company distributes its products through independent distributors, direct salespeople, and patients. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Lewisville, Texas.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- enovis.com
News
- Enovis to Host Third Quarter 2026 Results Conference Call on November 5th
- electroCore (NASDAQ:ECOR) and Enovis (NYSE:ENOV) Head-To-Head Comparison
- Transcript: Enovis Q2 2026 Earnings Conference Call
- Critical Survey: Enovis (NYSE:ENOV) vs. Nexalin Technology (NASDAQ:NXL)
- Enovis becomes first multi-registry industry sponsor of AAOS Registry Program
- Enovis (NYSE:ENOV) Hits New 52-Week Low – What’s Next?
- Insider at Medical Device Maker Buys More Than 7,500 Shares
- What Makes Enovis (ENOV) a New Buy Stock
- Enovis (ENOV) Loses 33% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
- Enovis Boosts Surgical Robotics Portfolio With eCential Acquisition
Your note
Sign in to keep a note on ENOV — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BERRY PHILLIP BENJAMIN BEN | Chief Financial Officer | Stock Award(Grant) | Mar 8, 2026 | 158,596 |
| ENGERT OLIVER | Officer | Purchase | Sep 3, 2026 | 63,898 |
| LANG PATRICIA A | Officer | Stock Award(Grant) | Mar 8, 2026 | 75,703 |
| MCDONALD DAMIEN | Chief Executive Officer | Purchase | Sep 3, 2026 | 247,077 |
| PRYOR DANIEL ALEXIS | Former | Sale | Dec 8, 2025 | 0 |
| ROSS TERRY D | Officer | Stock Award(Grant) | Mar 8, 2026 | 68,477 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 17.85% | 10,295,666 | 205.91M | Jun 29, 2026 |
| American Century Companies Inc | 10.59% | 6,106,561 | 122.13M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 6.81% | 3,926,268 | 78.53M | Jun 29, 2026 |
| Rubric Capital Management LP | 6.76% | 3,900,000 | 78.00M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.31% | 2,484,318 | 49.69M | Jun 29, 2026 |
| State Street Corporation | 4.27% | 2,462,788 | 49.26M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.95% | 3,431,569 | 68.63M | Sep 29, 2026 |
| American Century Capital Portfolios, Inc.-Small Cap Value Fund | 4.54% | 2,620,000 | 52.40M | Jun 29, 2026 |
| Fidelity Securities Fund-Fidelity Small Cap Value Fund | 4.04% | 2,328,360 | 46.57M | Jul 30, 2026 |
| American Century ETF Trust-Avantis U.S. Small Cap Value ETF | 3.80% | 2,189,182 | 43.78M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.98% | 1,719,530 | 34.39M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.59% | 1,493,643 | 29.87M | Sep 29, 2026 |